Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.
2.

Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.

Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Pandey RK, Tsuchida T, Dougherty TJ.

Cancer Res. 2003 Apr 15;63(8):1806-13.

3.

Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.

Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.

Cancer Res. 2001 Aug 1;61(15):5824-32.

4.

2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.

Lobel J, MacDonald IJ, Ciesielski MJ, Barone T, Potter WR, Pollina J, Plunkett RJ, Fenstermaker RA, Dougherty TJ.

Lasers Surg Med. 2001;29(5):397-405.

PMID:
11891727
6.

Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy.

Bellnier DA, Greco WR, Nava H, Loewen GM, Oseroff AR, Dougherty TJ.

Cancer Chemother Pharmacol. 2006 Jan;57(1):40-5. Epub 2005 Nov 5.

PMID:
16001178
7.

Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.

de Bruijn HS, Sluiter W, van der Ploeg-van den Heuvel A, Sterenborg HJ, Robinson DJ.

Photodermatol Photoimmunol Photomed. 2006 Oct;22(5):238-46.

PMID:
16948825
8.

Noninvasive extramammary Paget's disease treated with photodynamic therapy: case series from the Roswell Park Cancer Institute.

Housel JP, Izikson L, Zeitouni NC.

Dermatol Surg. 2010 Nov;36(11):1718-24. doi: 10.1111/j.1524-4725.2010.01734.x. Epub 2010 Sep 17.

PMID:
20849546
9.

Lack of effect of sex and disease state on the pharmacokinetics of porfimer sodium.

Houle JM, Clervoix N, Bain S, Spénard J.

Clin Pharmacokinet. 2006;45(9):923-30.

PMID:
16928153
10.

Distribution and pharmacokinetics of Photofrin in human bile duct cancer.

Pahernik SA, Dellian M, Berr F, Tannapfel A, Wittekind C, Goetz AE.

J Photochem Photobiol B. 1998 Nov;47(1):58-62.

PMID:
10052154
12.
13.

A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.

Orenstein A, Kostenich G, Roitman L, Shechtman Y, Kopolovic Y, Ehrenberg B, Malik Z.

Br J Cancer. 1996 Apr;73(8):937-44.

14.

Cellular distribution and phototoxicity of benzoporphyrin derivative and Photofrin.

Rousset N, Vonarx V, Eléouet S, Carré J, Bourré L, Lajat Y, Patrice T.

Res Exp Med (Berl). 2000 Jun;199(6):341-57.

PMID:
10945652
15.

Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.

Murakami H, Kohno E, Kohmura Y, Ozawa H, Ito H, Sugihara K, Horiuchi K, Hirano T, Kanayama N.

Photodermatol Photoimmunol Photomed. 2009 Oct;25(5):259-63. doi: 10.1111/j.1600-0781.2009.00457.x.

PMID:
19747245
16.

In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells.

Chang CJ, Sun CH, Liaw LH, Berns MW, Nelson JS.

Lasers Surg Med. 1999;24(3):178-86.

PMID:
10229148
17.

Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.

Furukawa K, Yamamoto H, Crean DH, Kato H, Mang TS.

Lasers Surg Med. 1996;18(2):157-66.

PMID:
8833284
18.

Endobronchial photodynamic therapy for lung cancer.

Loewen GM, Pandey R, Bellnier D, Henderson B, Dougherty T.

Lasers Surg Med. 2006 Jun;38(5):364-70. Review.

PMID:
16788932
19.

Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.

Mĺkvy P, Messmann H, Regula J, Conio M, Pauer M, Millson CE, MacRobert AJ, Bown SG.

Neoplasma. 1998;45(3):157-61.

PMID:
9717528
20.

Supplemental Content

Support Center